DRKS00003304已完成不适用
Identification of biomarkers, functional parameters and clinical risk factors predisposing for the development of pulmonary chronic GVHD after allogeneic hematopoietic stem cell transplantation.
Westdeutsches TumorzentrumKlinik für KnochenmarktransplantationUniversitätsklinikum Essen0 个研究点目标入组 125 人开始时间: 2011年11月2日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 125
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •free of relapse after allogeneic HSCT
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
Identification of genetic and functional biomarkers that predict PPAR-gamma-associated fluid retention and oedemaEUCTR2008-001634-28-GBniversity of Dundee
招募中
不适用
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment. Two-Part Research: Part BF00.2Alzheimer's diseaseMild Cognitive ImpairmentF00.0F00.1F00.9F06.7Dementia in Alzheimer disease with early onsetDementia in Alzheimer disease with late onsetDementia in Alzheimer disease, atypical or mixed typeDementia in Alzheimer disease, unspecifiedMild cognitive disorderDRKS00003705QUALISSIMA150
已完成
不适用
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a two-part clinical study. Part A: Multisite MRI Acquisition - Protocol Harmonization Part B: Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment: a clinical studyNL-OMON38870Vrije Universiteit Medisch Centrum15
已完成
不适用
Identification of biomarkers sensitive to disease progression in patients with Mild Cognitive Impairment. Two-part Research: Part AHealthy SubjectsMild Cognitive ImpairmentAlzheimer's disease / Alzheimer dementiaF00.0F00.1F00.2F00.9F06.7Dementia in Alzheimer disease with early onsetDementia in Alzheimer disease with late onsetDementia in Alzheimer disease, atypical or mixed typeDementia in Alzheimer disease, unspecifiedMild cognitive disorderDRKS00003721QUALISSIMA40
招募中
不适用
Identification of biomarker and clarification of resistance mechanism in immune checkpoint inhibitor therapyon-small cell lung cancer Kidney cancer Malignant melanoma Classical Hodgkin's lymphoma Head and neck cancer Gastric cancer Urothelial cancer Microsatellite instability-high (MSI-H) solid tumorJPRN-UMIN000027091Kanagawa Cancer Center Research Institute560